Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative Colitis [Phase 2]
Phase 2 pilot study evaluating green tea extract (Polyphenon E) for mild to moderately active ulcerative colitis has completed with results …
-
CLINICAL_TRIALS trial_result · 2017-12-07Clinical Trial Update: Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort
This clinical trial update reports the completion of a longitudinal cohort study on autoimmune paradoxical reactions in inflammatory bowel d…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Golimumab Dried Blood Spot Analysis [Phase 4]
Phase 4 trial update on golimumab examining dried blood spot analysis. The study targets Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis
The update reports clinical outcomes for ulcerative colitis patients managed with escalation and de-escalation of adalimumab in real-world c…
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis [Phase 1]
Phase 1 single ascending dose and multiple ascending dose study in healthy volunteers and ulcerative colitis patients; the trial has been te…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) [Phase 4]
Phase 4 clinical trial update evaluating golimumab (MK-8259) utilization and impact in ulcerative colitis with completed results.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
The document summarizes a clinical trial comparing the pharmacokinetic performance of the biosimilar SB2-infliximab to the originator inflix…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: An Efficacy and Safety Study of PENTASA in Chinese Patients With Left-sided Active Ulcerative Colitis Followed by a 24-Week Open-Label Extension Phase [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of PENTASA in Chinese patients with left-sided active ulcerative colitis has completed, i…
-
CLINICAL_TRIALS trial_result · 2017-09-25Clinical Trial Update: The NOR-SWITCH Study [Phase 4]
Phase 4 clinical trial update for NOR-SWITCH study; completed with multiple inflammatory diseases assessed.
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Fecal Microbiota Transplantation in Ulcerative Colitis [Phase 2]
Phase 2 clinical trial update on fecal microbiota transplantation for ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Manitoba Inflammatory Bowel Disease Cohort Study
Clinical trial update shows the Manitoba inflammatory bowel disease cohort study is completed, focusing on Crohn's disease and Ulcerative co…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial of QBECO for moderate-to-severe ulcerative colitis has completed, reporting on safety and efficacy outcomes.
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Budesonide 9 mg Capsules in Active UC [Phase 2]
A Phase 2 trial evaluating budesonide 9 mg capsules for active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Self-Management Assistance for Recommended Treatment (SMART) Portal
The SMART Portal clinical trial, sponsored by Cincinnati Children's Hospital Medical Center, has completed and evaluated a self-management p…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 [Phase 1]
This first-in-human Phase 1 trial evaluates the safety, tolerability, and pharmacokinetics of GSK1399686 in inflammatory bowel diseases and …
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis [Phase 2]
A Phase 2a trial evaluating the safety, tolerability, and efficacy of TOP1288 200 mg rectal solution once daily for 4 weeks in Ulcerative Co…
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis [NA]
A clinical trial evaluating the probiotic Propionibacterium freudenreichii for mild to moderate ulcerative colitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-06-26Clinical Trial Update: Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis [Phase 2]
Phase 2 trial results for GSK1399686 in mild to moderately active ulcerative colitis have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Granulocyte-monocyte Apheresis in Ulcerative Colitis [NA]
This clinical trial update confirms the completion of a study evaluating granulocyte-monocyte apheresis for ulcerative colitis (NCT03189888)…
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Propionyl-L-Carnitine in Ulcerative Colitis [Phase 2]
Phase 2 clinical trial of Propionyl-L-Carnitine for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) [Phase 3]
A Phase 3 study of LT-02 for mesalamine-refractory ulcerative colitis has been terminated, with the study status recorded as TERMINATED.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Oral OKT3 for the Treatment of Active Ulcerative Colitis [Phase 1, Phase 2]
Results from a Phase 1/2 clinical trial evaluating oral muromonab-CD3 (OKT3) for active ulcerative colitis; the study has completed and resu…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: A Phase 1b Study to Assess the Safety and Anti-inflammatory Effects of Two Different Doses of SRT2104 in Patients With Ulcerative Colitis [Phase 1]
A Phase 1b study evaluated the safety and anti-inflammatory effects of two doses of SRT2104 in patients with Ulcerative Colitis, and the tri…
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Detection of Helicobacter Pylori in Ulcerative Colitis Patients [NA]
This clinical trial update examines detection of Helicobacter pylori in patients with ulcerative colitis; the current status of the trial is…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects [Phase 1]
Phase 1 study evaluating safety and tolerability of TOP1288 administered rectally in healthy subjects and patients with Ulcerative Colitis; …